Apotex Corp. recalls Paxil CR
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
- Products
-
- Paxil CR
- Company
- Apotex Corp.
- Where it was sold
-
US Nationwide.
Nationwide
- Units affected
- 6,972 bottles
- About this recall
- Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3